Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Sees Large Decline in Short Interest

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the recipient of a large decline in short interest in the month of September. As of September 30th, there was short interest totaling 5,000 shares, a decline of 37.5% from the September 15th total of 8,000 shares. Based on an average daily trading volume, of 87,000 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 87,000 shares, the days-to-cover ratio is presently 0.1 days.

Reviva Pharmaceuticals Stock Down 2.8%

RVPHW stock opened at $0.04 on Wednesday. The firm’s 50 day moving average price is $0.05 and its 200-day moving average price is $0.05. Reviva Pharmaceuticals has a one year low of $0.02 and a one year high of $0.78.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.